Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
2.190
-0.080 (-3.52%)
Dec 3, 2024, 10:34 AM EST - Market open
Nautilus Biotechnology Employees
Nautilus Biotechnology had 167 employees as of December 31, 2023. The number of employees increased by 33 or 24.63% compared to the previous year.
Employees
167
Change (1Y)
33
Growth (1Y)
24.63%
Revenue / Employee
n/a
Profits / Employee
-$420,419
Market Cap
274.99M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 167 | 33 | 24.63% |
Dec 31, 2022 | 134 | 21 | 18.58% |
Dec 31, 2021 | 113 | 56 | 98.25% |
Dec 31, 2020 | 57 | - | - |
Related Stocks
Company Name | Employees |
---|---|
AngioDynamics | 748 |
OraSure Technologies | 638 |
Lexicon Pharmaceuticals | 285 |
LifeMD | 211 |
Vanda Pharmaceuticals | 203 |
Tenaya Therapeutics | 140 |
Mersana Therapeutics | 123 |
Aclaris Therapeutics | 91 |
NAUT News
- 4 weeks ago - Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research's Distinguished Investigator Award - GlobeNewsWire
- 4 weeks ago - Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Nautilus Biotechnology, Inc. (NAUT) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Nautilus Biotechnology, Inc. (NAUT) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Nautilus Biotechnology Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 5 months ago - Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024 - GlobeNewsWire
- 7 months ago - Nautilus Biotechnology, Inc. (NAUT) Q1 2024 Earnings Call Transcript - Seeking Alpha
- 7 months ago - Nautilus Biotechnology Reports First Quarter 2024 Financial Results - GlobeNewsWire